4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000899243-22-013487
CEO sold 6,261 shares at $59.11 ($370,088)
- CEO acquired 56,250 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Evans John M. CEO | 2022-03-31 | Grant or award | +56,250 | 1,095,331 | D | ||
| Evans John M. CEO | 2022-03-31 | Sale | −6,261 | $59.11 | $370,088 | 1,089,070 | D |
| Open-market sales · 6,261 sh · avg $59.11 · $370,088 | |||||||
Loading xslF345X03/doc4.xml…